RECURRENT ENDOMETRIAL CARCINOMA
Clinical trials for RECURRENT ENDOMETRIAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT ENDOMETRIAL CARCINOMA trials appear
Sign up with your email to follow new studies for RECURRENT ENDOMETRIAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New triple-threat treatment tested for tough-to-treat gynecologic cancers
Disease control OngoingThis study is testing whether combining three existing cancer drugs works better than current options for women whose endometrial, ovarian, fallopian tube, or primary peritoneal cancer has returned or stopped responding to platinum chemotherapy. The trial will enroll 38 participa…
Matched conditions: RECURRENT ENDOMETRIAL CARCINOMA
Phase: PHASE2 • Sponsor: Floor Backes, MD • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New drug combo tested in battle against Tough-to-Treat gynecologic cancers
Disease control OngoingThis early-stage study is testing a combination of two drugs, niraparib (a pill) and copanlisib (an IV infusion), for women whose ovarian, endometrial, or related cancers have returned after prior treatment. The main goals are to find the safest dose of this combination and to le…
Matched conditions: RECURRENT ENDOMETRIAL CARCINOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New drug combo trial offers hope for Tough-to-Treat uterine cancer
Disease control OngoingThis study is testing whether adding a drug called ribociclib to a two-drug combination (everolimus and letrozole) works better for women with advanced or returning endometrial cancer. The trial will enroll 90 participants to see if the three-drug combo helps control the cancer l…
Matched conditions: RECURRENT ENDOMETRIAL CARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Cancer-Killing virus tested in women with advanced uterine cancer
Disease control OngoingThis early-stage trial is testing the safety and best dose of a specially engineered virus designed to infect and kill endometrial cancer cells while sparing healthy ones. The virus can be tracked in the body using imaging. Some participants also receive an oral drug that may hel…
Matched conditions: RECURRENT ENDOMETRIAL CARCINOMA
Phase: PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Major trial tests new weapon against advanced uterine cancer
Disease control OngoingThis large, late-stage study is testing whether adding an immunotherapy drug called pembrolizumab to standard chemotherapy works better for treating advanced or recurrent endometrial cancer. It involves over 800 patients with stage III, IV, or returning cancer. The goal is to see…
Matched conditions: RECURRENT ENDOMETRIAL CARCINOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 25, 2026 14:09 UTC